Two-year outcomes of pulmonary vein isolation and cava-tricuspid isthmus radiofrequency ablation vs pharmacological only antiarrhythmic therapy: a single center experience
Open Access
- 31 January 2022
- journal article
- Published by OU Scientific Route in EUREKA: Health Sciences
- No. 1,p. 10-16
- https://doi.org/10.21303/2504-5679.2022.002278
Abstract
The benefit of radiofrequency ablation (RFA) in rhythm control in atrial fibrillation (AF) and flutter patients is uncertain, but risk of death, arrhythmia recurrence and other post ablation complications remains high. Existing data on the impact of pulmonary vein isolation and cava-tricuspid isthmus RFA on long-term prognosis of patients with AF and flutter and its advantage over pharmacological antiarrhythmic therapy (AAT) are insufficient and contradictory. The aim: we sought to evaluate two-year outcomes of pulmonary vein isolation and cava-tricuspid isthmus RFA vs pharmacological only AAT according to a single center experience. Material and methods: we enrolled 174 patients after pulmonary vein isolation RFA, cava-tricuspid isthmus RFA and their combination and 122 patient who did not undergo RFA and got pharmacological AAT only. Results: there was no significant difference in mortality between the RFA and AAT only groups (5.8 % and 9.0 % respectively) with the same structure of causes of death. The Caplan-Meyer curve analysis demonstrated better survivance (p=0.031) after RFA just during first year of observation. RFA effectiveness in arrhythmia relapse prevention was the highest for cava-tricuspid isthmus RFA procedure and worst – in group of combined pulmonary vein isolation and cava-tricuspid isthmus procedures. RFA showed an advantage over AAT in smaller quantities of non-fatal cardiovascular events (pConclusions: RFA of pulmonary vein isolation and cava-tricuspid isthmus RFA decrease arrhythmia episodes frequency, risk of non-fatal cardiovascular events and cardiovascular hospitalizations. Timely combined PVI and CTI procedure is associated with worsening of all outcomes.Keywords
This publication has 20 references indexed in Scilit:
- Biomarkers Determining Prognosis of Atrial Fibrillation AblationCurrent Medicinal Chemistry, 2019
- Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort studyInternational Journal of Clinical Practice, 2018
- Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysisInternational Journal of Cardiology, 2018
- Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014European Heart Journal, 2018
- Atrial fibrillation and heart failure- results of the CASTLE-AF trialJournal of Community Hospital Internal Medicine Perspectives, 2018
- Defining Blanking Period Post-Pulmonary Vein Antrum IsolationJACC: Clinical Electrophysiology, 2017
- Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UKPragmatic and Observational Research, 2017
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEuropean Heart Journal, 2016
- Meta-Analysis of Ablation of Atrial Flutter and Supraventricular TachycardiaThe American Journal of Cardiology, 2009
- Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluationHealth Technology Assessment, 2008